Company: FTII
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001641172-25-025250
Chunk: 39

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 8
Chunk 39
---
PubCo as the surviving company of the Reorganization Merger, and (iii) immediately following the consummation of the Reorganization Merger,
Longevity will merge with and into Merger Sub (the “Acquisition Merger”) with Longevity as the surviving company of the Acquisition
Merger. Following the Acquisition Merger, Longevity will be a wholly-owned subsidiary of PubCo. At the closing of the Transactions (the
“Closing”), PubCo’s common stock, par value $0.0001 per share (the “PubCo Common Stock”), is expected to
list on the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “LBIO.” The date on which the Closing
actually occurs is hereinafter referred to as the “Closing Date.”

Pursuant
to the Merger Agreement, Longevity shall, prior to the closing of the Reorganization Merger, consummate the Target Acquisitions upon
the terms and subject to conditions set forth therein and pursuant to the Target Acquisition Agreements. The Target Acquisitions are
the acquisitions by Longevity of each of Cerevast Medical, Inc. and Aegeria Soft Tissue, LLC (“Aegeria”) pursuant to each
of the Cerevast Acquisition Agreement and the Aegeria Acquisition Agreement, each in accordance with the respective terms thereof.

On
August 12, 2025, the Company consented (the “Approval of Waiver”) to Longevity entering into a waiver agreement with Aegeria
(the “Waiver Agreement”) to remove the restriction contained in the Aegeria Acquisition Agreement that prohibited Aegeria
from soliciting, negotiating, entering into, or otherwise facilitating an acquisition proposal or alternative transaction.

Special
Meeting 

As
approved by its stockholders at the special meeting of stockholders held on August 14, 2025, FutureTech II Acquisition Corp
(“FutureTech” or the “Company”) filed a Fourth Amendment (the “Fourth Amendment”) to its
Amended and Restated Certificate of Incorporation (the “Charter”) with the Delaware Secretary of State on August 15, 2025
to modify the terms and extend the date (the “Business Combination Period”) by which the Company has to consummate an initial
business combination (the “Business Combination”) for twelve one-month extensions from August 18, 2025 to August 18, 2026,
provided that the Company deposits the lesser of